Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2017

44 views

Published on

Market Research Reports, Inc. has announced the addition of “Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2017” research report to their offering. See more at - http://mrr.cm/Uix

Published in: Healthcare
  • Be the first to comment

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2017

  1. 1. www.MarketResearchReports.com Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.
  2. 2. www.MarketResearchReports.com Introduction to Report  Launch Date: July 25, 2017  Number of Pages: 98  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 2,000 Price For Site User License: USD 4,000 Price For Global User License: USD 6,000 Delivery Time: Within 24 Hours (During Working Days)
  3. 3. www.MarketResearchReports.com About the Report Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2017, provides an overview of the Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline landscape. Chemotherapy induced nausea and vomiting or CINV is nausea and vomiting that results specifically from treatment with chemotherapy drugs. Symptoms include a rapid heart rate, sweating, dizziness and increased saliva.
  4. 4. www.MarketResearchReports.com Report Highlights; This report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Nausea and Vomiting (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects.
  5. 5. www.MarketResearchReports.com Report Highlights; Continues… The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 1, 2, 6, 3, 1, 11, 3 and 3 respectively. Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
  6. 6. www.MarketResearchReports.com Scope: The pipeline guide provides a snapshot of the global therapeutic landscape of Chemotherapy Induced Nausea and Vomiting (Toxicology). The pipeline guide reviews pipeline therapeutics for Chemotherapy Induced Nausea and Vomiting (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre- registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  7. 7. www.MarketResearchReports.com Scope: Continues… The pipeline guide reviews key companies involved in Chemotherapy Induced Nausea and Vomiting (Toxicology) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Chemotherapy Induced Nausea and Vomiting (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Chemotherapy Induced Nausea and Vomiting (Toxicology)
  8. 8. www.MarketResearchReports.com Reasons to buy: Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. Find and recognize significant and varied types of therapeutics under development for Chemotherapy Induced Nausea and Vomiting (Toxicology). Classify potential new clients or partners in the target demographic. Develop tactical initiatives by understanding the focus areas of leading companies. Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  9. 9. www.MarketResearchReports.com Reasons to buy: Continues… Formulate corrective measures for pipeline projects by understanding Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline depth and focus of Indication therapeutics. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know- how what drove them from pipeline.
  10. 10. www.MarketResearchReports.com Report Coverage: 1. Introduction 2. Report Coverage 3. Chemotherapy Induced Nausea and Vomiting - Overview 4. Chemotherapy Induced Nausea and Vomiting - Therapeutics Development 5. Chemotherapy Induced Nausea and Vomiting - Therapeutics Assessment 6. Chemotherapy Induced Nausea and Vomiting - Drug Profiles 7. Chemotherapy Induced Nausea and Vomiting - Dormant Projects 8. Appendix For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  11. 11. www.MarketResearchReports.com Company Coverage: (Partial List) 1. Acacia Pharma Ltd 2. Aphios Corp 3. Astellas Pharma Inc 4. Athenex Inc 5. Camurus AB 6. Daewoong Pharmaceutical Co Ltd 7. Heron Therapeutics Inc 8. Insys Therapeutics Inc 9. Kyowa Hakko Kirin Co Ltd 10. MannKind Corp 11. Medlab Clinical Ltd 12. N4 Pharma Plc 13. Nanoform Cardiovascular Therapeutics Ltd For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  12. 12. www.MarketResearchReports.com Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @ http://www.marketresearchreports.com/idea-center For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to- newsletter
  13. 13. www.MarketResearchReports.com How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: http://mrr.cm/Uix About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Mr. Sudeep Chakravarty Email : info@marketresearchreports.com Phone: +1-302-703-9904 (USA) +91-8762746600 (India)

×